Gregory Weaver

Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA.

Verity Solutions Group, Inc. specializes in software and services developed for administration of the federal 340B drug pricing program. Its solutions include split billing, contract pharmacy, specialty contract pharmacy, audit & compliance services, compliance manager, purchase analytics and VHUB. The company was founded by James E. Torina in 2002 and is headquartered in Kirkland, WA.

Prism Technologies, Inc. provides ebusiness enterprise solutions. It is a subsidiary of Watch Hill Investment Partners, Inc. and is headquartered in North Providence, RI.

ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX.

SCOLR Pharma, Inc. is a pharmaceutical company, engages in proprietary and patented Controlled Delivery Technology platforms to develop and commercialize novel prescription, over-the-counter and nutritional products. The company's technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its lead product candidate is a CDT-based extended release formulation of ibuprofen, an analgesic typically used for the treatment of pain, fever and inflammation. SCOLR Pharma was founded in 1983 and is headquartered in Bellevue, WA.

Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA.

Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA.

Part of Dentsu Group, Inc., Oncology, Inc. provides oncology treatment information. The company is based in Cherry Hill, NJ. Oncology was acquired by Aegis Group Plc on January 07, 2008.

Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA.

BioIntelliSense, Inc. engages in developing a medical grade data services platform for continuous health monitoring, predictive analytics and algorithmic clinical insights. The company was founded by James Ritchie Mault in 2018 and is headquartered in Redwood City, CA.